C71
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age: = 18 years, known lesion in the cerebrum (shown by image based diagnostic) (tumor of the brain, lymphoma or metastasis), written informed consent
Exclusion criteria
Exclusion criteria: General contra-indication for MRT, inability to lie quiescent for 60 min (due to pain, claustrophobia, etc.), insulin-dependent Diabetes mellitus or glucose-value >120 mg/dl , precnancy/ breast feeding women, limited contractual capability or underage person
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dynamic determination of glucose-uptake of tumors after injection of glucose (iv) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Correlation of glucoCEST contrast with conventional imaging (T1w, T2w, ADC, DCE-T1w), native CEST and PET-contrast (if available), 2. Correlation of glucoCEST-signals with survival and progression-free survival, 3. Comparison of glucoCEST-signals with amid-CEST (without glucose injection) | — |
Countries
Germany
Contacts
Radiologische Klinik, Universitätsklinikum Tübingen, Abt. Neuroradiologie